ArticleCureus2023

Intravitreal Bevacizumab for Choroidal Neovascular Membrane in Macular Telangiectasia Type 2.

Orlando G Gonzalez Martinez et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.